Kendle adds OmniComm’s TrialMaster EDC solution to e-clinical offerings
Leading global CRO Kendle announced in October that it will add OmniComm’s TrialMaster EDC solution to its current e-clinical offerings in a multi-year enterprise-wide agreement.
To continue reading this article, subscribe for FREE to
Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.
Here are some related topics that may interest you:
Published In
Volume 5 - Issue 11 | November 2009








